Pharm Tech Minutes 2012.10.24
Revision as of 07:25, 12 December 2012 by Juergenbrandstaetter (talk | contribs)
09:00 - 09:30 Welcome
- Welcome
- Call to Order/Roll Call
- IHE
- Juergen Brandstaetter
- Jacqueline Surugue
- Michael Tan
- Marc Robberecht
- Eric Poiseau
- Leonidas Tzimis
- Simon Letellier
- Jose Costa Teixeira
- Stephen Chu
- HL7
- Tom de Jong
- Melva Peters
- Jean Duteau
- Nicolas Canu
- Hugh Glover
- Julie James
- Review and Approve Agenda
- Approved
09:30 - 10:00 Wrap-up last year
- Progress since the last meeting and forward plans on each side
- HL7
- Prepared topics in HL7 Pharmacy for ballot (extensive process)
- Some already normative, others still in progress
- HL7 V3 Pharmacy material formerly intended to be used in Community Pharmacy, but now also prepared for Institutional Pharmacy (= Hospital Pharmacy). This work is almost finished.
- Work on Medication profile work-item
- Proposals for future work/collaboration
- Work on storyboards could be shared or beind done collaborated, because they are usually the same
- How do we make sure that people adopt the standards of HL7 and IHE since that pair results in the "way to use all the material in the right way"?
- Todo: Jürgen will provide a slide with the statement, will be shaped between the co-chairs until suitable
- IHE
- Maintenance of profiles
- No big changes, exceptional cases added
- Doing marketing for Deployment
- Collaborative work with PCD according "Administration devices"
- Work on Medication Documentation
- IHE International strategic change
10:00 - 12:15 Strategie for increasing adoption and deployment of both IHE and HL7
- Tom presents the layers of interoperability
- TRANSPORT
- XDS, AORTA, ...
- PACKAGING
- Messages, CDA
- CONTENT
- Data model, Terminology
- CONCEPTS (hard to standardize by HL7 or IHE)
- Semantics, Glossary
- Discussion about enhancing the flexibilty of IHE profiles in order to also fit to "message-based" archtictures, e.g. Cananda
- We realized that also the Canada topology contains also a central repository and therefore it's not that much different to the CMPD model, except that CMPD relies on XDS only at the moment
- In order to do that there are the following Todos:
- New IHE work-item: Will check the separation of CMPD actors into "Content Creator" and "Transport" actors and evaluates if the grouping with XDR/XDM would also be possible
- Jürgen
- New Joint work-item: "Standardized content": Agree on a common data model for e.g. Prescription and subsequently decide if to change/enhance PRE profile or create an alternative second content profile (similar for other content types)
- Jürgen, Tom
- Evaluate the creation of a CMPD.b profile which shall be consider topologies without central repository (e.g. US approach of sending the prescription directly to the Pharmacy)
- We agree that this is main difference in topology (central registry existing or not)
- Considered as important but second priority. Postponed until first item is completed
12:15 - 13:00 --- Lunch ---
13:00 - 14:30 Medication Profile (with break)
- Yesterday's outcome
- Proposal for continuing tomorrow:
- 1) Approve the hierarchy of Stephen's slides
- 2) Discuss and approve each definition within the hierarchy
- 3) Define next steps
- Review of Stephen's presentation
- Decisions
- Terms have to harmonized in a glossary in context of their usage
- Glossary will be done during shaping the definitions
- Use-cases shall be created and shall come from a wide community
- Parallel to the work on the hierarchy/definitions a second work-item will be worked our bottom-up and which describes data-sources and the according nature of the data as well as related aspects necessary to provide the data needed by the other work-item
- The term "reconsiliation" has two meanings:
- 1) Matching data with reality (e.g. by asking the patient)
- 2) Finding the right future medication by considering the past medication and clinical situation of the patient
- Agreed term for (1): Medication Reconsiliation
- Agreed term for (2): Medication Revision
- Todo
- Stephen will consolidate the slide deck and combines the terms in the hierarchy with the definitions formerly sent. Will send to both groups when done (within 2 weeks)
- Jacqueline, Stephen, Melva, Leonidas will provide use-cases, Michael reviews
- Jose takes the lead of the second work-item. Approved that work on this work-item may start immediately.
- Next steps
- Wait for Stephen's slides
- Jacqueline on behalf of all use-case makers will communicate the decision if a TCon is needed before use-cases will be created (within 2 weeks after slides received)
15:00 - 15:15 --- Break ---
15:15 - 16:00 Pharmacy CDA Mapping Project
- Introduction of project
- Primary goal: Mapping of HL7 Pharmacy Message Types information elements to suitable CDA R2 information elements
- Second goal: Stylesheet for automatic generation
- Interest in following or participating?
- Collaborative work implicitly given by work-item "Standardized content" and following work-items
- Extend CDA Schema (for IHE Pharmacy) will be provided to Tom and Michael
- Michael will check if NICTIZ could provided resources for doing the mapping
- Suggested tool for mapping: Altova MapForce (or similars)
16:00 - 16:15 Review of recent change in Pharmacy CMET in 2011
- See CP-PHARM-035
- Are there any more changes to expect in the near future?
- Yes, it's because Substances became a section of the Common Product Model
- Recommendation of HL7 Pharmacy: Wait at least to Common Product Model Release 12 (currently Rel 10)
- Release Number does not correspond to Normative Edition numbering!
16:15 - 16:30 Glossary work item
- Status
- Marco and Derrek Evans have worked on it
- No information about the current status
- Expected end of the work-item can not be estimated because work on it is on hold at the moment
- Yesterday's outcome
- Sync with ISO Glossary (SKMT) necessary?
- Discussion
- Melva: It's not clear, if this is globally well accepted. It's more a "gathering" tool which allows multiple definitions for terms without governance
- Nicolas: SKMT names itself "Glossary" but its rather a dictionary. A glossary should always be seen in some context
- Decision
- Should definately be used as a source for our common glossary
- Contributing our terms to SKMT once we decided on our preferred definitions
16:30 - 17:00 Any other business
- ISO plans a new work item "Drug dictionary" - what is our standpoint?
- Julie reports
- A small group will prepare a proposal for the "Requirements of a drug dictionary"
- Not clear if an international or national drug dictionary?
- Discussion
- Hugh: It's inapproriate to begin such a piece of work when the IDMP standard (referred by the new item) is not yet finalized.
- Jacqueline: The requirements differ a lot even within countries.
- Decision
- Wait for the actual proposal
- Frank Gener sends PHAST document: "The Functional Interoperability Framework for Automated Systems Integration in Electronic Medication Management Processes"
- IHE identifies this document to be related to HMW and Supply Chain
- Mostly already covered by the Supply Chain Whitepaper, because of synchronized work in the past
- Document will be put to FTP in subfolder "Resources" to folder "Supply Chain" whitepaper
- HL7
- Document will be published internally
- Will be evaluated in the future
Next meetings
- IHE
- F2F meeting in March 18-19, 2013 at Arsenal-IT, Treviso, Italy
- IHE offer to HL7:
- Join our meeting on the 19th and HL7 adds 2 days for you own
- Is expected not to be problem for Arsenal-IT
- Todo Jürgen: Will contact Claudio if it's possible and inform HL7 co-chair
- F2F meeting in June 11-12, 2013 at Nictiz, Den Haag, Netherlands
- IHE offer to HL7:
- Join our meeting on the 12th and HL7 adds 2 days for you own
- Nictiz confirms this possibility
- No F2F meetings are defined for season yet
- IHE would be willing to plan March's and October's meeting together with HL7 in order to do a joint day on both
- IHE also has access to quite some locations (sponsored) which could also be extended to HL7 group
- HL7
- No future out-of-cycle meetings planned
- March could be possible
- Decision most likely not before Jan 2013
- Regulary meetings:
- Jan 13-18, 2013, Phoenix
- May 5-10, 2013, Atlanta
- Sep 22-27, 2013, Camebridge/Massachussets